BFM
ALNY icon

Boothbay Fund Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Boothbay Fund Management’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-55,400
Closed -$13.5M – 1588
2024
Q2 		$13.5M Buy
55,400
+21,400
+63% +$3.38M 0.32% 42
2024
Q1 		$5.08M Sell
34,000
-5,700
-14% -$951K 0.1% 221
2023
Q4 		$7.6M Buy
+39,700
New +$6.76M 0.19% 102
2022
Q4 		– Sell
-34,800
Closed -$6.97M – 1974
2022
Q3 		$6.97M Sell
34,800
-1,500
-4% -$286K 0.17% 100
2022
Q2 		$5.29M Buy
36,300
+20,500
+130% +$2.91M 0.14% 165
2022
Q1 		$2.58M Sell
15,800
-3,900
-20% -$594K 0.06% 468
2021
Q4 		$3.34M Buy
19,700
+1,900
+11% +$353K 0.08% 308
2021
Q3 		$3.36M Sell
17,800
-4,200
-19% -$788K 0.09% 261
2021
Q2 		$3.73M Buy
+22,000
New +$3.22M 0.12% 189
2020
Q2 		– Sell
-310
Closed -$3.37M – 946
2020
Q1 		$3.37M Buy
+310
New +$35.8K 0.28% 83
2019
Q4 		– Sell
-192
Closed -$1.54M – 835
2019
Q3 		$1.54M Buy
+192
New +$15.2K 0.14% 201
2018
Q4 		– Sell
-115
Closed -$1.01M – 647
2018
Q3 		$1.01M Buy
+115
New +$11.6K 0.1% 208
2017
Q4 		– Sell
-25
Closed -$294K – 701
2017
Q3 		$294K Buy
+25
New +$2.13K 0.05% 379

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Boothbay Fund Management's ALNY Position: Q3 2025 in Review

Boothbay Fund Management sold out of Alnylam Pharmaceuticals (ALNY) in Q3 2025, closing a stake of 19,213 shares — an estimated $6.27M sold.

Boothbay Fund Management first reported a position in ALNY in Q2 2017 and held it in 11 quarters. The position peaked at $6.27M in Q2 2025. 822 funds tracked by Wall St. Rank hold ALNY as of Q3 2025.

  • Boothbay Fund Management reported no remaining Alnylam Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Boothbay Fund Management sold 19,213 Alnylam Pharmaceuticals shares in Q3 2025, an estimated $6.27M.
  • Boothbay Fund Management first reported a position in Alnylam Pharmaceuticals in Q2 2017 and held it in 11 quarters.
  • Boothbay Fund Management's Alnylam Pharmaceuticals position peaked at $6.27M in Q2 2025.
  • 822 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q3 2025.

Based on Boothbay Fund Management's 13F filing for Q3 2025, filed 14 Nov 2025.